story of the week
Dimethyl Fumarate Is Associated With Lower Rates of Infection and Infection-Related Health Care Costs Than Ocrelizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders